GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for ...

Co-authors reported grants from Takeda Pharmaceuticals and UCB, consulting for GlaxoSmithKline, and personal fees from the ...

The incident's legacy extends far beyond CrowdStrike. Organizations now implement staged rollouts and maintain manual override capabilities.

Recent developments illustrate dynamic shifts in the healthcare sector. Trump's spending bill is anticipated to challenge ...

GSK has shifted towards a global marketing model influenced by a Netflix-style approach that aims to match content to the person receiving it. Richard Staines heard about this new strategy at the ...

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

Britain's life sciences sector plan receives a mixed reception from the pharmaceutical industry. While the strategy aims to boost R&D, industry leaders criticize the lack of resolution on drug pricing ...

Real-world deployment patterns show customers using multiple AI models simultaneously, forcing a fundamental shift in enterprise AI architecture.

At e4m TechManch 2025, CX leaders across telecom, retail, pharma, and tech explored how AI, data, and design are redefining ...

When Hein Schumacher's exit from Unilever signaled pressure for performance, Rohit Jawa faced the challenge of maintaining ...

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.